Celon Pharma SA
WSE:CLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celon Pharma SA
WSE:CLN
|
PL |
|
V
|
Vital Healthcare Property Trust
NZX:VHP
|
NZ |
|
Signify NV
AEX:LIGHT
|
NL |
|
F
|
FSBM Holdings Bhd
KLSE:FSBM
|
MY |
|
Sandesh Ltd
NSE:SANDESH
|
IN |
Intrinsic Value
Is CLN undervalued or overvalued?
See the intrinsic value estimate for Celon Pharma SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CLN looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CLN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Celon Pharma Does
Celon Pharma SA is a Polish pharmaceutical company that develops, manufactures, and sells medicines. Its business includes both its own drug development programs and established prescription products, with a focus on areas such as nervous system disorders, oncology, and other specialist treatments. It also works with drug substances and manufacturing capabilities that support its own portfolio and outside customers.
- Headquarters
- Poland PL
- Employees
- 566
- IPO date
- Dec 1, 2016
Revenue & Expenses Breakdown
Celon Pharma SA
Earnings Waterfall
Celon Pharma SA
The intrinsic value for Celon Pharma SA (CLN) under the Base Case is hidden PLN.
Compared with the current market price of 19 PLN, the stock appears hidden.